Mawi DNA is working with Biotessia to start a local production site for DNA sample collection technologies and kits. These will be provided to African markets at a significantly lower cost.
Mawi DNA Technologies (Mawi), a leading biosample collection company, is engaging in a joint venture with Moroccan medical device company BIOTESSIA to serve the African market.
The goal of Mawi DNA and Biotessia’s joint venture is to produce DNA/RNA, Forensics, Microbiome and blood room temperature stable bio-sample collection technologies and kits in Morocco, targeting African and European countries. Aiming to provide high quality DNA sampling at more affordable prices.
The two companies secured a grant from Morocco’s government for 25% of the capital required to start the project The funding will support Biotessia’s vision to distribute diagnostic tests that help detect common diseases in Morocco and Africa, especially in the rural and secluded areas of the continent.
Economic Sustainability For Biobanking Long-Term Storage And Stability...
"Biobanking of these samples creates opportunities for new research, resolution of numerous unanswered questions." Biobanking has increasingly become a popular research tool to analyze hum...
READ MOREUnraveling the DNA Collection Procedure and Fundamentals of Obtaining DNA…...
In the quest for unraveling the mysteries hidden within the intricate strands of DNA, the process of DNA collection emerges as the pivotal gateway to a world of invaluable genetic insights. DNA collec...
READ MORE
